|
| Gadd45 stress sensors in suppression of leukemia |
|
https://doi.org/10.18632/oncotarget.26154
David L. Wiest
|
| 34191-34192 |
|
| CDK4/6 inhibitors in hormone receptorpositive human epidermal growth factor receptor 2 HER2negative metastatic breast cancer: Are we at the finish line |
|
https://doi.org/10.18632/oncotarget.26134
Clinton Yam, Mien-Chie Hung, and Gabriel N. Hortobagyi
|
| 34193-34195 |
|
| Metastasisdirected therapy: a new standard for oligorecurrent prostate cancer |
|
https://doi.org/10.18632/oncotarget.26152
Thomas Zilli, and Piet Ost
|
| 34196-34197 |
|
| The ubiquitinactivating enzyme UBA1 as a novel therapeutic target for AML |
|
https://doi.org/10.18632/oncotarget.26153
Samir H. Barghout, and Aaron D. Schimmer
|
| 34198-34199 |
|
| Carnosol suppresses patientderived gastric tumor growth by targeting RSK2 |
|
https://doi.org/10.18632/oncotarget.24409
Li Wang, Yujuan Zhang, Kangdong Liu, Hanyong Chen, Ran Yang, Xiaoli Ma, Hong-Gyum Kim, Ann M. Bode, Dong Joon Kim, and Zigang Dong
|
| 34200-34212 |
|
| Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GMCSF and IFNα as an effective therapeutic vaccine adjuvant |
|
https://doi.org/10.18632/oncotarget.25789
Weidong Zhao, Gan Zhao, Shuren Zhang, Xianzheng Wang, Xueping Yu, and Bin Wang
|
| 34213-34228 |
|
| Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles |
|
https://doi.org/10.18632/oncotarget.26026
Takeshi Sawada, Riet Hilhorst, Savithri Rangarajan, Masayuki Yoshida, Yuko Tanabe, Kenji Tamura, Takayuki Kinoshita, Tatsu Shimoyama, Rinie van Beuningen, Rob Ruijtenbeek, Hitoshi Tsuda, and Fumiaki Koizumi
|
| 34229-34239 |
|
| Heat shock protein 90 inhibitors overcome the resistance to Fmslike tyrosine kinase 3 inhibitors in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.26045
Kazuhiro Katayama, Kohji Noguchi, and Yoshikazu Sugimoto
|
| 34240-34258 |
|
| The role of AP1 in selfsufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop |
|
https://doi.org/10.18632/oncotarget.26047
Sherif Abd El-Fattah Ibrahim, Aierken Abudu, Eugenia Johnson, Neelum Aftab, Susan Conrad, and Michele Fluck
|
| 34259-34278 |
|
| Spatiotemporal tumor heterogeneity in metastatic CRC tumors: a mutationalbased approach |
|
https://doi.org/10.18632/oncotarget.26081
SofÃa del Carmen, José MarÃa Sayagués, Oscar Bengoechea, MarÃa Fernanda Anduaga, Jose Antonio Alcazar, Ruth Gervas, Jacinto GarcÃa, Alberto Orfao, Luis Muñoz Bellvis, MarÃa Eugenia Sarasquete, and MarÃa del Mar Abad
|
| 34279-34288 |
|
| Molecular dynamics simulation reveals the possible druggable hotspots of USP7 |
|
https://doi.org/10.18632/oncotarget.26136
Mitul Srivastava, Charu Suri, Mrityunjay Singh, Rajani Mathur, and Shailendra Asthana
|
| 34289-34305 |
|
| Oncogenic driver FGFR3TACC3 is dependent on membrane trafficking and ERK signaling |
|
https://doi.org/10.18632/oncotarget.26142
Katelyn N. Nelson, April N. Meyer, Clark G. Wang, and Daniel J. Donoghue
|
| 34306-34319 |
|
| Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.26144
Yoshinobu Shigekawa, Shinya Hayami, Masaki Ueno, Atsushi Miyamoto, Norihiko Suzaki, Manabu Kawai, Seiko Hirono, Ken-ichi Okada, Ryuji Hamamoto, and Hiroki Yamaue
|
| 34320-34335 |
|
| The efficacy of rechallenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study |
|
https://doi.org/10.18632/oncotarget.26149
Julia K. Tietze, Andrea Forschner, Carmen Loquai, Heidrun Mitzel-Rink, Lisa Zimmer, Frank Meiss, David Rafei-Shamsabadi, Jochen Utikal, Maike Bergmann, Friedegund Meier, Nicole Kreuzberg, Max Schlaak, Carsten Weishaupt, Claudia Pföhler, Mirjana Ziemer, Michael Fluck, Jessica Rainer, Markus V. Heppt, and Carola Berking
|
| 34336-34346 |
|
| Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study |
|
https://doi.org/10.18632/oncotarget.26151
Stephen McCain, James Trainor, Damian T. McManus, Úna C. McMenamin, Stephen McQuaid, Victoria Bingham, Jacqueline A. James, Manuel Salto-Tellez, Richard C. Turkington, and Helen G. Coleman
|
| 34347-34356 |
|
| Functional characterization of phospholipase Cγ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder |
|
https://doi.org/10.18632/oncotarget.26173
Claudia Walliser, Martin Wist, Elisabeth Hermkes, Yuan Zhou, Anja Schade, Jennifer Haas, Julia Deinzer, Laurent Désiré, Shawn S.C. Li, Stephan Stilgenbauer, Joshua D. Milner, and Peter Gierschik
|
| 34357-34378 |
|
| A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells |
|
https://doi.org/10.18632/oncotarget.26193
William P. Katt, Nicolas J. Blobel, Svetlana Komarova, Marc A. Antonyak, Ichiro Nakano, and Richard A. Cerione
|
| 34379-34397 |
|
| Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.26146
Maurizio Cavallari, Francesco Cavazzini, Antonella Bardi, Eleonora Volta, Aurora Melandri, Elisa Tammiso, Elena Saccenti, Enrico Lista, Francesca Maria Quaglia, Antonio Urso, Michele Laudisi, Elisa Menotti, Luca Formigaro, Melissa Dabusti, Maria Ciccone, Paolo Tomasi, Massimo Negrini, Antonio Cuneo, and Gian Matteo Rigolin
|
| 34398-34412 |
|
| Genes involved in the regulation of different types of autophagy and their participation in cancer pathogenesis |
|
https://doi.org/10.18632/oncotarget.26126
Martyna Bednarczyk, Nikola Zmarzły, Beniamin Grabarek, Urszula Mazurek, and Małgorzata Muc-Wierzgoń
|
| 34413-34428 |
|
| Prominent role of histone lysine demethylases in cancer epigenetics and therapy |
|
https://doi.org/10.18632/oncotarget.24319
Avilala Janardhan, Chandrasekhar Kathera, Amrutha Darsi, Wajid Ali, Lingfeng He, Yanhua Yang, Libo Luo, and Zhigang Guo
|
| 34429-34448 |
|
| Correction: Acute myeloid leukemia with t4;12q12;p13: an aggressive disease with frequent involvement of PDGFRA and ETV6 |
|
https://doi.org/10.18632/oncotarget.26205
Jingyi Li, Jie Xu, Lynne V. Abruzzo, Guilin Tang, Shaoying Li, M. James You, Gary Lu, Elias J. Jabbour, Qi Deng, Carlos E. Bueso-Ramos, L. Jeffrey Medeiros, and C. Cameron Yin
|
| 34449-34449 |
|
| Erratum: Actinbinding protein alphaactinin 4 ACTN4 is a transcriptional coactivator of RelA/p65 subunit of NFkB |
|
https://doi.org/10.18632/oncotarget.26206
Vasilisa Aksenova, Lidia Turoverova, Mikhail Khotin, Karl-Eric Magnusson, Eugene Tulchinsky, Gerry Melino, George P. Pinaev, Nickolai Barlev, and Dmitri Tentler
|
| 34450-34450 |
